You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Purpura, Thrombocytopenic

Showing 51 - 75 of 1,066
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023

Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069)

Enrolling by invitation
  • Idiopathic Thrombocytopenic Purpura
  • GNR-069
  • Irkutsk, Irkutsk Region, Russian Federation
  • +12 more
Aug 5, 2022

Thrombotic Thrombocytopenic Purpura, Acquired Trial in Beijing (Bortezomib Injection)

Not yet recruiting
  • Thrombotic Thrombocytopenic Purpura, Acquired
  • Bortezomib Injection
  • Beijing, (Select), China
    Peking Union Medical College Hospital
Nov 22, 2021

Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • +2 more
  • Singapore, Singapore
    Novartis Investigative Site
Jan 17, 2023

ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Sep 27, 2022

Crohn Disease, Ulcerative Colitis, Celiac Disease Trial in Hong Kong (Fecal Microbiota Transplantation)

Recruiting
  • Crohn Disease
  • +26 more
  • Fecal Microbiota Transplantation
  • Hong Kong, Shatin, Hong Kong
    The Chinese University of Hong Kong
Feb 10, 2022

Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)

Completed
  • Primary Immune Thrombocytopenia
  • Shandong, China
    Qilu Hospital of Shandong University
Nov 20, 2022

Immune Thrombocytopenia, Purpura, Thrombocytopenic Trial in Jinan (Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone)

Not yet recruiting
  • Immune Thrombocytopenia
  • Purpura, Thrombocytopenic
  • Atorvastatin 20mg
  • +2 more
  • Jinan, Shandong, China
    Qilu hospital, Shandong University
Aug 30, 2021

Immune Thrombocytopenia Trial (Terbutaline, Danazol)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
Aug 6, 2022

The ConNeCT Study: Neurological Complications of TTP

Recruiting
  • Thrombotic Thrombocytopenic Purpura
  • Questionnaires (including PHQ-9, TYM and SF-36)
  • Liverpool, United Kingdom
    Royal Liverpool University Hospital
Aug 2, 2021

Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies

Completed
  • Idiopathic Purpura
    • Montpellier, France
      Uhmontpellier
    Oct 22, 2021

    Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Treatment
    • CM313 Injection
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Jan 12, 2023

    Functional Activity of Platelets for Differential Diagnosis of

    Not yet recruiting
    • Immune Thrombocytopenia
    • +3 more
    • Flow cytometry
    • Platelet aggregation and plasma coagulation
    • (no location specified)
    Dec 8, 2022

    Thrombotic Thrombocytopenic Purpura Trial in United States (rituximab)

    Completed
    Has Results
    • Thrombotic Thrombocytopenic Purpura
    • rituximab
    • Atlanta, Georgia
    • +3 more
    Aug 13, 2021

    Relapsed/Refractory Immune Thrombocytopenia Trial in Seoul (Bortezomib)

    Not yet recruiting
    • Relapsed/Refractory Immune Thrombocytopenia
    • Seoul, Korea, Republic of
    • +1 more
    Oct 30, 2022

    Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in Graz (potential biomarkers)

    Recruiting
    • Immune Thrombocytopenia
    • +3 more
    • potential biomarkers
    • Graz, Styria, Austria
      Pediatric Hematology-Oncology Outpatient Clinic
    Sep 8, 2022

    Immune Thrombocytopenia Trial in Bristol (Mycophenolate Mofetil, Prednisolone)

    Completed
    • Immune Thrombocytopenia
    • Bristol, United Kingdom
      University Hospital Bristol NHS Foundation Trust
    Oct 25, 2022

    Idiopathic Thrombocytopenic Purpura Trial in Cairo (Eltrombopag, conventional)

    Completed
    • Idiopathic Thrombocytopenic Purpura
    • Cairo, Egypt
      Ainshams University , Faculty of medicine , Pediatric Hematology
    Oct 26, 2021

    Congenital Thrombotic Thrombocytopenic Purpura Trial in Worldwide (TAK-755)

    Recruiting
    • Congenital Thrombotic Thrombocytopenic Purpura
    • TAK-755
    • Atlanta, Georgia
    • +20 more
    Mar 29, 2022

    Purpura, Thrombocytopenic, Idiopathic, Autoimmune Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Autoimmune Trial in

    Terminated
    • Purpura, Thrombocytopenic, Idiopathic
    • +2 more
    • veltuzumab
    • Los Angeles, California
    • +7 more
    Aug 12, 2021

    Immune Thrombocytopenic Purpura (ITP) Trial in Worldwide (Immune Globulin Intravenous (Human), 10% Triple Virally Reduced

    Completed
    • Immune Thrombocytopenic Purpura (ITP)
    • Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
    • Brno, Czechia
    • +10 more
    Apr 29, 2021

    Immune Thrombocytopenia Trial in Jena

    Recruiting
    • Immune Thrombocytopenia
      • Jena, Germany
        University Hospital Jena
      Mar 29, 2022

      Immune Thrombocytopenia Trial in Beijing (TAC, Danazol)

      Recruiting
      • Immune Thrombocytopenia
      • Beijing, Beijing, China
        Peking University Insititute of Hematology, Peking University Pe
      Jul 20, 2022

      Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)

      Recruiting
      • Primary Immune Thrombocytopenia
      • Ianalumab
      • +2 more
      • Singapore, Singapore
        Novartis Investigative Site
      Jan 23, 2023

      Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

      Recruiting
      • Immune Thrombocytopenia
      • Suzhou, Jiangsu, China
        Jie Yin
      Apr 19, 2022